# Amoxicillin/Clavulanic Acid Susceptibility in Acute Community-acquired Pneumonia Requiring Intensive Care Management

> **NCT07322549** · — · COMPLETED · sponsor: **Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer** · enrollment: 104 (actual)

## Conditions studied

- Severe Community-acquired Pneumonia

## Interventions

- **OTHER:** Susceptibility to AMC
- **OTHER:** Susceptibilty to 3GC

## Key facts

- **NCT ID:** NCT07322549
- **Lead sponsor:** Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-03-01
- **Primary completion:** 2025-09-30
- **Final completion:** 2025-09-30
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2026-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07322549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07322549, "Amoxicillin/Clavulanic Acid Susceptibility in Acute Community-acquired Pneumonia Requiring Intensive Care Management". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07322549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
